BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 2013;59:367-74. [PMID: 23557870 DOI: 10.1016/j.jhep.2013.03.026] [Cited by in Crossref: 75] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Cardoso FS, Karvellas CJ. Respiratory Complications Before and After Liver Transplant. J Intensive Care Med 2019;34:355-63. [PMID: 29886790 DOI: 10.1177/0885066618781526] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sundaram SS, Mack CL, Feldman AG, Sokol RJ. Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care. Liver Transpl. 2017;23:96-109. [PMID: 27650268 DOI: 10.1002/lt.24640] [Cited by in Crossref: 89] [Cited by in F6Publishing: 64] [Article Influence: 22.3] [Reference Citation Analysis]
3 Bloom PP, Rodriguez-Lopez J, Witkin AS, Al-Samkari H, Kuter DJ, Mojtahed A, Luther J. Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia. Clin Transl Gastroenterol 2020;11:e00118. [PMID: 31977452 DOI: 10.14309/ctg.0000000000000118] [Reference Citation Analysis]
4 Segraves JM, Cartin-Ceba R, Leise MD, Krowka MJ. Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works. Hepatol Res 2018;48:E340-6. [PMID: 28667665 DOI: 10.1111/hepr.12930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 DeMartino ES, Krowka MJ. Pulmonary Vascular Complications of Liver Disease. Int Anesthesiol Clin 2017;55:67-80. [PMID: 28225533 DOI: 10.1097/AIA.0000000000000140] [Reference Citation Analysis]
6 Raghunathan V, Mohan N, Dhaliwal M, Bhangui P, Vohra V, Soin AS. Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post-transplant hypoxemia-a single center experience. Pediatr Transplant 2020;24:e13792. [PMID: 32881212 DOI: 10.1111/petr.13792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lv Y, Han G, Fan D. Portopulmonary hypertension. Scandinavian Journal of Gastroenterology 2016;51:795-806. [DOI: 10.3109/00365521.2016.1157895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: An update and review of the literature. World J Hepatol. 2017;9:1197-1204. [PMID: 29152039 DOI: 10.4254/wjh.v9.i31.1197] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
9 Krowka MJ, Heimbach JK. Portopulmonary hypertension and liver transplantation: A duo in question. Liver Transpl 2016;22:1633-4. [DOI: 10.1002/lt.24664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Ecochard-Dugelay E, Lambert V, Schleich JM, Duché M, Jacquemin E, Bernard O. Portopulmonary Hypertension in Liver Disease Presenting in Childhood. J Pediatr Gastroenterol Nutr 2015;61:346-54. [PMID: 25885880 DOI: 10.1097/MPG.0000000000000821] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 4.2] [Reference Citation Analysis]
11 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 458] [Article Influence: 220.0] [Reference Citation Analysis]
12 Dubrock HM, Channick RN, Krowka MJ. What’s new in the treatment of portopulmonary hypertension? Expert Review of Gastroenterology & Hepatology 2015;9:983-92. [DOI: 10.1586/17474124.2015.1035647] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
13 Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival. Liver Transpl. 2015;21:1355-1364. [PMID: 26077312 DOI: 10.1002/lt.24198] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
14 Laici C, Gamberini L, Bardi T, Siniscalchi A, Reggiani MLB, Faenza S. Early infections in the intensive care unit after liver transplantation-etiology and risk factors: A single-center experience. Transpl Infect Dis. 2018;20:e12834. [PMID: 29359867 DOI: 10.1111/tid.12834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Wong KKY, Wong CWY. A review of long-term outcome and quality of life of patients after Kasai operation surviving with native livers. Pediatr Surg Int 2017;33:1283-7. [DOI: 10.1007/s00383-017-4158-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
16 Liberal R, Grant CR, Baptista R, Macedo G. “Porto-pulmonary hypertension: a comprehensive review”. Clin Res Hepatol Gastroenterol. 2015;39:157-167. [PMID: 25659878 DOI: 10.1016/j.clinre.2014.12.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Rodriguez-Roisin R, Bartolome SD, Huchon G, Krowka MJ. Inflammatory bowel diseases, chronic liver diseases and the lung. Eur Respir J. 2016;47:638-650. [PMID: 26797027 DOI: 10.1183/13993003.00647-2015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
18 Nayyar D, Man HSJ, Granton J, Gupta S. Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome: POST-LT Hypoxemia in HPS. Liver Transpl 2014;20:182-90. [DOI: 10.1002/lt.23776] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
19 DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension. Pulm Circ 2016;6:498-507. [PMID: 28090291 DOI: 10.1086/688489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
21 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 294] [Article Influence: 61.3] [Reference Citation Analysis]
22 DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation 2017;101:1609-15. [PMID: 28207639 DOI: 10.1097/TP.0000000000001666] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
23 Spiro MD, Eilers H. Intraoperative Care of the Transplant Patient. Anesthesiology Clinics 2013;31:705-21. [DOI: 10.1016/j.anclin.2013.09.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
24 Reymond M, Barbier L, Salame E, Besh C, Dumortier J, Pageaux GP, Bureau C, Dharancy S, Vanlemmens C, Abergel A, Woehl Jaegle ML, Magro P, Patat F, Laurent E, Perarnau JM. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study. Transplantation. 2018;102:616-622. [PMID: 29077657 DOI: 10.1097/tp.0000000000001981] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 5.7] [Reference Citation Analysis]
25 Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072-8081. [PMID: 25009379 DOI: 10.3748/wjg.v20.i25.80729] [Reference Citation Analysis]
26 Al-naamani N, Roberts KE. Portopulmonary Hypertension. Clinics in Chest Medicine 2013;34:719-37. [DOI: 10.1016/j.ccm.2013.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016;100:1440-1452. [PMID: 27326810 DOI: 10.1097/tp.0000000000001229] [Cited by in Crossref: 161] [Cited by in F6Publishing: 37] [Article Influence: 40.3] [Reference Citation Analysis]
28 Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173-92. [PMID: 32114503 DOI: 10.1136/gutjnl-2019-320221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
29 Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072-8081. [PMID: 25009379 DOI: 10.3748/wjg.v20.i25.8072] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
30 Moeckli B, Majno P, Orci LA, Peloso A, Toso C. Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective. Semin Liver Dis 2021;41:172-81. [PMID: 33957694 DOI: 10.1055/s-0041-1723032] [Reference Citation Analysis]
31 DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplant Direct 2019;5:e456. [PMID: 31321292 DOI: 10.1097/TXD.0000000000000900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
32 Muller YD, Oppliger R, Breguet R, Meyer P, Rubbia-Brandt L, Petignat PA, Harr T, Dayer E, Seebach JD. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation? Liver Int 2016;36:1735-40. [PMID: 27864873 DOI: 10.1111/liv.13187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Fussner LA, Krowka MJ. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension. Curr Gastroenterol Rep. 2016;18:29. [PMID: 27098816 DOI: 10.1007/s11894-016-0504-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
34 Demartino ES, Cartin-ceba R, Findlay JY, Heimbach JK, Krowka MJ. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation. Transplantation 2017;101:101-6. [DOI: 10.1097/tp.0000000000001517] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
35 Deroo R, Trépo E, Holvoet T, De Pauw M, Geerts A, Verhelst X, Colle I, Van Vlierberghe H, Fallon MB, Raevens S. Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta‐Analysis. Hepatology 2020;72:1701-16. [DOI: 10.1002/hep.31164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
36 Santos J, Young P, Barjaktarevic I, Lazar C, Susanto I, Wang T. The successful use of inhaled nitric oxide in the management of severe hepatopulmonary syndrome after orthotopic liver transplantation. Case Reports Hepatol 2014;2014:415109. [PMID: 25374726 DOI: 10.1155/2014/415109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
37 Ogawa E, Hori T, Doi H, Segawa H, Uemoto S. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience. Clin Transplant. 2014;28:1031-1040. [PMID: 24986560 DOI: 10.1111/ctr.12415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
38 Clark VC. Liver Transplantation in Alpha-1 Antitrypsin Deficiency. Clin Liver Dis 2017;21:355-65. [PMID: 28364818 DOI: 10.1016/j.cld.2016.12.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
39 Bauer M, Fuhrmann V, Wendon J. Pulmonary complications in liver disease. Intensive Care Med 2019;45:1433-5. [PMID: 31375864 DOI: 10.1007/s00134-019-05721-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 DuBrock HM, Krowka MJ. The Myths and Realities of Portopulmonary Hypertension. Hepatology 2020;72:1455-60. [PMID: 32515501 DOI: 10.1002/hep.31415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
41 Rajaram P, Spivey J, Fisher M. Novel role of midodrine in pulmonary hypertension in liver transplant candidates. Liver Transpl 2016;22:1034-6. [PMID: 27090347 DOI: 10.1002/lt.24467] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Zhao H, Tsauo J, Zhang XW, Ma HY, Weng NN, Tang GS, Li X. Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake. World J Gastroenterol 2020;26:1088-97. [PMID: 32205999 DOI: 10.3748/wjg.v26.i10.1088] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Krowka MJ, Cartin-Ceba R. Portopulmonary hypertension: formidable dual threat versus hopeful dual therapy. Liver Transpl. 2014;20:635-636. [PMID: 24711442 DOI: 10.1002/lt.23885] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
44 Rajaram P, Parekh A, Fisher M, Kempker J, Subramanian R. Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience. Transplant Proc 2017;49:338-43. [PMID: 28219595 DOI: 10.1016/j.transproceed.2016.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014;20:352-7. [PMID: 24811830 DOI: 10.1097/MCP.0000000000000058] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
46 Lv Y, Han G, Fan D. Hepatic Hydrothorax. Ann Hepatol 2018;17:33-46. [PMID: 29311408 DOI: 10.5604/01.3001.0010.7533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
47 Matsuura T, Yoshimaru K, Yanagi Y, Esumi G, Hayashida M, Taguchi T. Massive pulmonary hemorrhage before living donor liver transplantation in infants. Pediatr Transplant 2016;20:89-95. [PMID: 26691206 DOI: 10.1111/petr.12650] [Reference Citation Analysis]
48 Huang B, Shi Y, Liu J, Schroder PM, Deng S, Chen M, Li J, Ma Y, Deng R. The early outcomes of candidates with portopulmonary hypertension after liver transplantation. BMC Gastroenterol 2018;18:79. [PMID: 29879915 DOI: 10.1186/s12876-018-0797-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Chen XJ, Zhu ZJ, Sun LY, Wei L, Zeng ZG, Liu Y, Qu W, Zhang L. Liver transplantation for severe portopulmonary hypertension: A case report and literature review. World J Clin Cases 2019;7:3569-74. [PMID: 31750339 DOI: 10.12998/wjcc.v7.i21.3569] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Bessho K. Complications and Quality of Life in Long-Term Survivors of Biliary Atresia with Their Native Livers. The Journal of Pediatrics 2015;167:1202-6. [DOI: 10.1016/j.jpeds.2015.08.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]